Overprescription of short‐acting β(2)‐agonists among patients with asthma in Saudi Arabia: Results from the SABINA III cohort study

Despite near‐universal health care and timely updates to treatment guidelines in Saudi Arabia, asthma control remains suboptimal, warranting deeper exploration of its management practices. This study describes asthma characteristics and prescription patterns of short‐acting β(2)‐agonists (SABAs) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Al‐Jahdali, Hamdan, Wali, Siraj, Albanna, Amr S., Al Harbi, Abeer, Allehebi, Riyad, Arwadi, Abdulmajed, Dahan, Tarek, Fattouh, Mohamed, Hamza, Ezzat, Beekman, Maarten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716708/
https://www.ncbi.nlm.nih.gov/pubmed/36279888
http://dx.doi.org/10.1111/crj.13553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716708/
https://www.ncbi.nlm.nih.gov/pubmed/36279888
http://dx.doi.org/10.1111/crj.13553

Ejemplares similares